RaNA Therapeutics Receives $20,700,000 Series A Funding

  • Feed Type
  • Date
    1/18/2012
  • Company Name
    RaNA Therapeutics
  • Mailing Address
    25 First Street Cambridge, MA 02141
  • Company Description
    RaNA was initially named IncRNA Inc., possibly a reference to intergenic non-coding RNA, the RNA that doesn’t make proteins but still performs a cellular function.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,700,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The Series A funds will be used to accelerate R&D efforts across a range of disease areas, expand RaNA’s broad IP estate in the field of long non-coding RNA, and expand the core team.
  • M&A Terms
  • Venture Investor
    Atlas Venture
  • Venture Investor
    SR One
  • Venture Investor
    Monsanto

By posting a comment, you agree to our terms and conditions.